IgAN,malignant hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria (1) this study was approved by the ethics committee of the first medical center of the PLA General Hospital (ethics approval No.: s2021-165-01). The retrospective patients were exempted from signing informed consent, and the prospective patients voluntarily participated in this study and signed informed consent. (2) After 2013, patients with primary IgA nephropathy diagnosed by renal biopsy in the Department of Nephrology of the first medical center of the PLA General Hospital. (3) In hospital diagnosis of renal puncture with malignant hypertension [10], that is, the blood pressure is significantly elevated, usually > 200 / 120mmhg, and can be accompanied by significant bilateral retinopathy (flame hemorrhage, cotton wool spots or optic papilledema). (4) The age of renal biopsy was over 18 years old (including 18 years old), regardless of gender; (5) There was a questionnaire of traditional Chinese medicine within 7 days before and after renal biopsy.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) the number of evaluable glomeruli was less than 8; (2) Secondary IgA nephropathy such as purpura nephritis, lupus nephritis and hepatitis B; (3) Other renal diseases such as membranous nephropathy; (4) combined with diabetes, connective tissue disease and other systemic diseases. (5) The medical records are incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| no; | — |
Countries
China